Biotech · Private company

Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.

Track this companyFree. Adds Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials80 recruiting or active

Pipeline programs10From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline10

ApixabanPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
CiraparantagPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
EdoxabanPhase 2 · Anticoagulation ReversalClinicalTrials.gov · fetched Nov 12, 2026
enoxaparinPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Heparin SodiumPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
PER977Phase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
PER977Phase 2 · Anticoagulation ReversalClinicalTrials.gov · fetched Nov 12, 2026
RivaroxabanPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
14C PER977Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Single-armHealthyClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials8

Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCTPHASE2 · COMPLETED · started Aug 30, 2017ClinicalTrials.gov NCT03288454 · fetched Nov 12, 2026
Phase 2 Study of Rivaroxaban Reversal by Ciraparantag as Measured by WBCTPHASE2 · COMPLETED · started May 8, 2017ClinicalTrials.gov NCT03172910 · fetched Nov 12, 2026
An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male SubjectsPHASE1 · COMPLETED · started Jul 1, 2014ClinicalTrials.gov NCT02205905 · fetched Nov 12, 2026
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following HeparinPHASE1_PHASE2 · COMPLETED · started Jun 1, 2014ClinicalTrials.gov NCT02206087 · fetched Nov 12, 2026
PK and PD of Single, Escalating Doses of PER977 Following EnoxaparinPHASE1_PHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02206100 · fetched Nov 12, 2026
A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time MeasurementsNA · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02205827 · fetched Nov 12, 2026
Study of PER977 Administered to Subjects With Steady State Edoxaban Dosing and Re-anticoagulation With EdoxabanPHASE2 · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02207257 · fetched Nov 12, 2026
Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of EdoxabanPHASE1 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01826266 · fetched Nov 12, 2026